Abbott stock sank 10% on earnings — what traders watch before the bell
Abbott shares hovered near $109 in early premarket Friday after a 10% post-earnings drop, following a fourth-quarter revenue miss driven by weakness in nutrition and diagnostics. Nutrition sales fell 8.9% to $1.94 billion, while medical-device sales rose 12.3%. The company forecast first-quarter adjusted earnings of $1.12 to $1.18 per share and expects to close its Exact Sciences acquisition in Q2.